Biosciences Division

News

  • New ORNL process brings nanoparticles into focus

    Scientists can study the biological impacts of engineered nanomaterials on cells within the body with greater resolution than ever because of a procedure developed by researchers at the Department of Energy's Oak Ridge National Laboratory.

  • Audio Spot: New medicine therapeutics company is spinout from ORNL

    A Company, NellOne Therapeutics, has been formed through Battelle Ventures to research the potential for a new therapy that could help heart patients, according to Oak Ridge National Laboratory scientist Cymbeline Culiat.

In The News

Thomas Thundat has been elected a Fellow in the American Physical Society, an honor that is limited each year to no more than one-half of one percent of the society's current membership. Thundat is being honored for "...his pioneering work in developing micromechanical sensor platforms for biomolecular detection and the elucidation of the fundamental physical principles underlying the adsorption-induced forces." Thundat is a Distinguished R&D Staff Member and Group Leader of the Nanoscale Science and Devices Group in the Life Sciences Division.

Oak Ridge National Laboratory Review and ORNL Reporter

Review showcases research results and technology developments.
(How to subscribe)

News Articles